BioWorld

Aug. 16, 2002

ImClone Files $7M Suit Against Sam Waksal, Reports Earnings

ImClone Systems Inc. filed a lawsuit against its founder and former CEO, Sam Waksal, claiming he destroyed documents possibly relevant to a government investigation of the company's business practices. (BioWorld Today) Read More

Genaera Reduces Staff To Focus On Select Products

Texas Soil Yields Molecule Of Unprecedented Power; Ecopia, Academics Domesticating It

Ribozyme Expands Focus, Cuts Staff By 30 Employees

MedImmune Enters Deals With Biosite, ViroNovative

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Dec. 12, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Dec. 12, 2025.

CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials

BioWorld

A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...

DEE-lightful: Praxis’ phase II results allow stock to flex its muscle

BioWorld

Positive efficacy results led to Praxis Precision Medicines Inc.’s phase II Embold study in developmental and epileptic encephalopathies (DEEs) being halted...

Illustration of head with maze that is missing parts

CTAD 2025: The challenges of combination therapies for dementia

BioWorld Science

At the Clinical Trials on Alzheimer’s Disease 2025 meeting, a panel of experts discussed the need for developing combination therapies for the complex diseases...